| Literature DB >> 25280339 |
S Noguchi1, M Kumazaki2, T Mori3, K Baba4, M Okuda4, T Mizuno1, Y Akao2.
Abstract
MicroRNA (miR)-203 is downregulated and acts as an anti-oncomir in melanoma cells. Here, using human and canine melanoma cells, we elucidated the effects of miR-203 on cyclic adenosine monophosphate response element binding protein (CREB)/microphthalmia-associated transcription factor (MITF)/RAB27a pathway, which is known to be important for the development and progression of human melanoma. In this study, we showed that miR-203 directly targeted CREB1 and regulated its downstream targets, MITF and RAB27a. miR-203 significantly suppressed the growth of human and canine melanoma cells and inhibited melanosome transport through the suppression of the signalling pathway. In conclusion, miR-203 was shown to be a common tumour-suppressive miRNA in human and canine melanoma and thus to play a crucial role in the biological mechanisms of melanoma development.Entities:
Keywords: CREB/MITF/RAB27a pathway; cell signalling; comparative oncology; melanoma; microRNA-203
Mesh:
Substances:
Year: 2014 PMID: 25280339 DOI: 10.1111/vco.12118
Source DB: PubMed Journal: Vet Comp Oncol ISSN: 1476-5810 Impact factor: 2.613